Collategene (beperminogene perplasmid) / AnGes MG, Mitsubishi Tanabe, Kamada, Er-Kim Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Collategene (beperminogene perplasmid) / AnGes MG, Mitsubishi Tanabe
NCT02016755: A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia

Completed
2b
10
US
HGF Plasmid, AMG0001
AnGes USA, Inc.
Critical Limb Ischemia, Vascular Diseases, Peripheral Arterial Disease
03/18
03/18
NCT00189540: Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

Completed
2
27
US
HGF plasmid, Placebo
AnGes USA, Inc.
Arterial Occlusive Disease, Peripheral Vascular Disease, Ischemia, Ulcers
07/08
08/08
NCT04267640: Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers

Recruiting
2
60
US
AMG0001, HGF plasmid, Collategene, beperminogene perplasmid, Placebo
AnGes USA, Inc.
Peripheral Artery Disease, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease, Chronic Limb Threatening Ischemia, Ischemic Ulcer of Foot
07/22
01/23

Download Options